Prolonged effects of dexamethasone following total knee arthroplasty: A pre‐planned sub‐study of the DEX‐2‐TKA trial
Acta Anaesthesiologica Scandinavica · 2024
DOI: 10.1111/aas.14319 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Acta Anaesthesiologica Scandinavica, 2024. Verfasst von Cecilie Bauer Derby und 13 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Anaesthesiological Research, Department of Anesthesiology, Zealand University Hospital, Køge, Denmark. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Naestved, Slagelse and Ringsted Hospitals' Research Fund, Department of Anaesthesiology, Naestved, Slagelse and Ringsted Hospitals, Zealand Region Research Foundation.
Abstract (Originalsprache)
Objectives
The DEX‐2‐TKA trial demonstrated that one and two doses of 24 mg intravenous dexamethasone reduced opioid consumption and pain after total knee arthroplasty (TKA). We aimed to investigate the prolonged effects of dexamethasone after the 48‐h intervention period.
Design
This was a prospective, pre‐planned questionnaire follow‐up on postoperative days 3–7 of patients in the DEX‐2‐TKA trial that randomly received: DX1 (dexamethasone 24 mg + placebo), DX2 (dexamethasone 24 mg + dexamethasone 24 mg), and placebo (placebo + placebo) perioperatively and 24 h later.
Setting
A multicenter trial performed at five Danish hospitals.
Participants
We analyzed 434 of 485 adult participants enrolled in the DEX‐2‐TKA trial. Outcome Measures Primary outcome was difference between groups in average of all numerical rating scale (NRS) pain scores reported in the morning, at bedtime, and the daily average pain on postoperative days 3–7. Secondary outcomes were sleep quality and patient satisfaction.
Results
The median (interquartile range) pain intensity levels for postoperative days 3–7 were: DX2 3.2 (2.1–4.3); DX1 3.3 (2.3–4.1); and placebo 3.3 (2.5–4.7). Hodges–Lehmann median differences between groups were: 0 (95% confidence interval − 0.54 to 0.2), P = 0.38 between DX1 and placebo; 0.1 (−0.47 to 0.33), p = .87 between DX1 and DX2; and 0.1 (−0.6 to 0.13), p = .20 between DX2 and placebo. We found no relevant differences between groups on sleep quality on postoperative days 3–7 nor for patient satisfaction with the analgesic treatment.
Conclusions
We found that neither one nor two doses of 24 mg intravenous dexamethasone demonstrated prolonged effects on overall pain or sleep quality on postoperative days 3–7 after total knee arthroplasty. We also found that dexamethasone had no effect on patient satisfaction. Trial registration number: Clinicaltrials.gov NCT03506789 (main result trial).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Anaesthesiological Research, Department of Anesthesiology, Zealand University Hospital, Køge, Denmark.
- Research Centre of Anaesthesiology and Intensive Care Medicine, Department of Anesthesiology, Naestved, Slagelse and Ringsted Hospitals, Naestved, Denmark.
- Department of Clinical Medicine, Copenhagen University, Copenhagen, Denmark.
- Department of Anaesthesia and Intensive Care, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.
- Department of Anaesthesia, Gildhøj Private Hospital, Brøndby, Denmark.
- Department of Anaesthesiology and Intensive Care, Odense University Hospital, Odense, Denmark.
ORCID-Profile: Cecilie Bauer Derby, Kasper Smidt Gasbjerg, Daniel Hägi-Pedersen, Stig Brorson, Kasper Højgaard Thybo, Martin Lindberg-Larsen, Søren Overgaard, Janus Christian Jakobsen, Ole Mathiesen
Förderung
- Naestved, Slagelse and Ringsted Hospitals' Research Fund
- Department of Anaesthesiology, Naestved, Slagelse and Ringsted Hospitals
- Zealand Region Research Foundation
Zitieren
APA
Derby, C. B., Gasbjerg, K. S., Hägi-Pedersen, D., Lunn, T. H., Pedersen, N. A., Lindholm, P., Brorson, S., Schrøder, H. M., Thybo, K. H., Bagger, J., Lindberg-Larsen, M., Overgaard, S., Jakobsen, J. C., & Mathiesen, O. (2024). Prolonged effects of dexamethasone following total knee arthroplasty: A pre‐planned sub‐study of the DEX‐2‐TKA trial. Acta Anaesthesiologica Scandinavica. https://doi.org/10.1111/aas.14319
Vancouver
Derby CB, Gasbjerg KS, Hägi-Pedersen D, Lunn TH, Pedersen NA, Lindholm P, et al. Prolonged effects of dexamethasone following total knee arthroplasty: A pre‐planned sub‐study of the DEX‐2‐TKA trial. Acta Anaesthesiologica Scandinavica. 2024. doi:10.1111/aas.14319
BibTeX
@article{Derby2024,
author = {Derby, Cecilie Bauer and Gasbjerg, Kasper Smidt and Hägi-Pedersen, Daniel and Lunn, Troels Haxholdt and Pedersen, Niels Anker and Lindholm, Peter and Brorson, Stig and Schrøder, Henrik Morville and Thybo, Kasper Højgaard and Bagger, Jens and Lindberg-Larsen, Martin and Overgaard, Søren and Jakobsen, Janus Christian and Mathiesen, Ole},
title = {Prolonged effects of dexamethasone following total knee arthroplasty: A pre‐planned sub‐study of the DEX‐2‐TKA trial},
journal = {Acta Anaesthesiologica Scandinavica},
year = {2024},
doi = {10.1111/aas.14319}
}
EUVIMED